USPTO serial 79444435
RADIO NANO THERAPEUTICS
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- BARRESE, TAYLOR ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RADIO NANO THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tiffany D. Gehrke
Tiffany D. Gehrke Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the prevention and treatment of cancer for human and animal; antitumor drugs for the treatment of cancer; radioactive substances for medical purposes; pharmaceutical preparations for in vivo diagnostics or therapeutic use; biological preparations for the treatment of cancer; veterinary preparations for the treatment of cancer; reagent paper for medical purposes; dental composite materials | ACTIVE | — |
| 042 | Testing, inspection or research services in the field of medical treatment methods and technology; Conducting product research and testing the functionality of on machines, apparatus and instruments for treatment or diagnostic purposes for human diseases; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; provision of information concerning testing, inspection, or research of pharmaceuticals, cosmetics or food; pharmaceutical product evaluation; Testing, research, inspection or development of pharmaceutical preparations for medical purposes in the field of cancerous diseases; Testing, research, inspection or development of medical preparations for cancer vaccine; research and development services in the field of cytology; pharmaceutical drug development services; research in the fields of chemistry, biology and physics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 30, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 30, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 18, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 18, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 31, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 26, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |